A
Price
$146.89
Change
-$4.63 (-3.06%)
Updated
Nov 13 closing price
Capitalization
41.64B
10 days until earnings call
Intraday BUY SELL Signals
BLCO
Price
$15.69
Change
-$0.91 (-5.48%)
Updated
Nov 13 closing price
Capitalization
5.56B
103 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

A vs BLCO

Header iconA vs BLCO Comparison
Open Charts A vs BLCOBanner chart's image
Agilent Technologies
Price$146.89
Change-$4.63 (-3.06%)
Volume$1.94M
Capitalization41.64B
Bausch + Lomb
Price$15.69
Change-$0.91 (-5.48%)
Volume$912.44K
Capitalization5.56B
A vs BLCO Comparison Chart in %
View a ticker or compare two or three
VS
A vs. BLCO commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is A is a Buy and BLCO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (A: $146.89 vs. BLCO: $15.69)
Brand notoriety: A and BLCO are both not notable
A represents the Medical Specialties, while BLCO is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: A: 117% vs. BLCO: 177%
Market capitalization -- A: $41.64B vs. BLCO: $5.56B
A [@Medical Specialties] is valued at $41.64B. BLCO’s [@Pharmaceuticals: Other] market capitalization is $5.56B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $200.47B to $0. The average market capitalization across the [@Medical Specialties] industry is $12.08B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

A’s FA Score shows that 3 FA rating(s) are green whileBLCO’s FA Score has 1 green FA rating(s).

  • A’s FA Score: 3 green, 2 red.
  • BLCO’s FA Score: 1 green, 4 red.
According to our system of comparison, A is a better buy in the long-term than BLCO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

A’s TA Score shows that 3 TA indicator(s) are bullish while BLCO’s TA Score has 5 bullish TA indicator(s).

  • A’s TA Score: 3 bullish, 5 bearish.
  • BLCO’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, BLCO is a better buy in the short-term than A.

Price Growth

A (@Medical Specialties) experienced а -0.41% price change this week, while BLCO (@Pharmaceuticals: Other) price change was +1.03% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.21%. For the same industry, the average monthly price growth was +1.82%, and the average quarterly price growth was +31.26%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.10%. For the same industry, the average monthly price growth was +0.50%, and the average quarterly price growth was +6.41%.

Reported Earning Dates

A is expected to report earnings on Nov 24, 2025.

BLCO is expected to report earnings on Feb 25, 2026.

Industries' Descriptions

@Medical Specialties (+1.21% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Pharmaceuticals: Other (+2.10% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
A($41.6B) has a higher market cap than BLCO($5.56B). A YTD gains are higher at: 10.026 vs. BLCO (-13.123). A has higher annual earnings (EBITDA): 1.8B vs. BLCO (454M). A has more cash in the bank: 1.54B vs. BLCO (266M). A has less debt than BLCO: A (3.41B) vs BLCO (4.96B). A has higher revenues than BLCO: A (6.79B) vs BLCO (4.89B).
ABLCOA / BLCO
Capitalization41.6B5.56B749%
EBITDA1.8B454M396%
Gain YTD10.026-13.123-76%
P/E Ratio34.32N/A-
Revenue6.79B4.89B139%
Total Cash1.54B266M577%
Total Debt3.41B4.96B69%
FUNDAMENTALS RATINGS
A: Fundamental Ratings
A
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
PROFIT vs RISK RATING
1..100
61
SMR RATING
1..100
44
PRICE GROWTH RATING
1..100
14
P/E GROWTH RATING
1..100
20
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABLCO
RSI
ODDS (%)
Bearish Trend 1 day ago
53%
Bearish Trend 1 day ago
78%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
61%
Bearish Trend 1 day ago
74%
Momentum
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
71%
MACD
ODDS (%)
Bearish Trend 1 day ago
63%
Bullish Trend 1 day ago
56%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
61%
Bullish Trend 1 day ago
70%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
60%
Bullish Trend 1 day ago
75%
Advances
ODDS (%)
Bullish Trend 3 days ago
61%
Bullish Trend 3 days ago
67%
Declines
ODDS (%)
Bearish Trend 5 days ago
59%
Bearish Trend 18 days ago
72%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
57%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
60%
Bullish Trend 1 day ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
A
Daily Signal:
Gain/Loss:
BLCO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSSMX12.01N/A
N/A
Morgan Stanley Inst Inception A
MLPDX5.86-0.01
-0.17%
Invesco SteelPath MLP Income A
AMFFX61.88-0.71
-1.13%
American Funds American Mutual F1
JSCVX23.75-0.30
-1.25%
Janus Henderson Small Cap Value T
WSCJX14.90-0.43
-2.80%
Allspring Disciplined Small Cap R6

A and

Correlation & Price change

A.I.dvisor indicates that over the last year, A has been closely correlated with MTD. These tickers have moved in lockstep 84% of the time. This A.I.-generated data suggests there is a high statistical probability that if A jumps, then MTD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To A
1D Price
Change %
A100%
-3.06%
MTD - A
84%
Closely correlated
-2.46%
WAT - A
81%
Closely correlated
-2.08%
RVTY - A
79%
Closely correlated
-0.78%
TMO - A
79%
Closely correlated
-1.34%
DHR - A
77%
Closely correlated
+0.82%
More

BLCO and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLCO has been loosely correlated with CRL. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if BLCO jumps, then CRL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLCO
1D Price
Change %
BLCO100%
-5.48%
CRL - BLCO
45%
Loosely correlated
-1.34%
MTD - BLCO
44%
Loosely correlated
-2.46%
RVTY - BLCO
44%
Loosely correlated
-0.78%
A - BLCO
43%
Loosely correlated
-3.06%
RMD - BLCO
42%
Loosely correlated
-0.30%
More